Irfen 200 mg
Irfen 200 mg is a medicine authorised by Swissmedic under authorisation number 67373. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 February 2019 and the authorisation is valid without a time limit. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 67373 |
|---|---|
| Name | Irfen 200 mg |
| Full name | Irfen 200 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AE01 |
| First authorisation | 21 February 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Irfen 200 mg, Filmtabletten | B | 21 February 2019 |
| 2 | Irfen 400 mg, Filmtabletten | B | 21 February 2019 |
| 3 | Irfen 600 mg, Filmtabletten | B | 21 February 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 7 | 30 | Tablette(n) | M01AE01 | 07.10.1. | B |
| 8 | 100 | Tablette(n) | M01AE01 | 07.10.1. | B |
| 9 | 20 | Tablette(n) | M01AE01 | 07.10.1. | B |
| 10 | 50 | Tablette(n) | M01AE01 | 07.10.1. | B |
| 11 | 20 | Tablette(n) | M01AE01 | 07.10.1. | B |
| 12 | 100 | Tablette(n) | M01AE01 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Irfen 200 mg authorised in Switzerland?
Yes. Irfen 200 mg is authorised by Swissmedic under authorisation number 67373, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Irfen 200 mg have?
Irfen 200 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Irfen 200 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.